SpringWorks Therapeutics (SWTX)
(Delayed Data from NSDQ)
$45.53 USD
+1.33 (3.01%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $45.55 +0.02 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/2/24 |
---|---|
Current Quarter | -1.17 |
EPS Last Quarter | -1.44 |
Last EPS Surprise | -15.20% |
ABR | 1.00 |
Earnings ESP
|
27.47% |
---|---|
Current Year | -4.69 |
Next Year | -3.26 |
EPS (TTM) | -5.14 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 11.88M | 20.26M | 95.77M | 256.66M |
# of Estimates | 5 | 5 | 5 | 4 |
High Estimate | 18.00M | 37.00M | 135.23M | 377.16M |
Low Estimate | 6.94M | 11.85M | 59.10M | 190.30M |
Year ago Sales | 0.00M | 0.00M | 5.45M | 95.77M |
Year over Year Growth Est. | NA | NA | 1,658.22% | 168.00% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.17 | -1.11 | -4.69 | -3.26 |
# of Estimates | 5 | 4 | 6 | 4 |
Most Recent Consensus | -1.10 | -1.01 | -3.83 | -4.23 |
High Estimate | -0.85 | -0.64 | -2.96 | -0.46 |
Low Estimate | -1.35 | -1.44 | -5.97 | -4.23 |
Year ago EPS | -1.18 | -1.25 | -5.15 | -4.69 |
Year over Year Growth Est. | 0.85% | 11.20% | 8.93% | 30.51% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 3 | 3 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 1 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.17 | -1.11 | -4.69 | -3.26 |
7 Days Ago | -1.19 | -1.14 | -4.71 | -3.27 |
30 Days Ago | -1.19 | -1.14 | -4.71 | -3.27 |
60 Days Ago | -1.19 | -1.18 | -4.71 | -3.81 |
90 Days Ago | -1.20 | -1.18 | -4.67 | -4.10 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.85 | -0.64 | -2.96 | -0.46 |
Zacks Consensus Estimate | -1.17 | -1.11 | -4.69 | -3.26 |
Earnings ESP | 27.47% | 42.08% | 36.93% | 85.90% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.44 | -1.27 | -1.25 | -1.18 | NA |
Estimate | -1.25 | -1.31 | -1.25 | -1.25 | NA |
Difference | -0.19 | 0.04 | 0.00 | 0.07 | -0.02 |
Surprise | -15.20% | 3.05% | 0.00% | 5.60% | -1.64% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more